Lina Shan

23 Youzheng Street
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension.

ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension.

Journal: Communications biology

Published: August 19, 2025

HIF1α/PRDX1 axis drives pulmonary vascular remodeling through DRP1 DeSUMOylation and mitochondrial fragmentation.

HIF1α/PRDX1 axis drives pulmonary vascular remodeling through DRP1 DeSUMOylation and mitochondrial fragmentation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 26, 2025

NDRG1-HIF1α interaction in hypoxic signaling for pulmonary hypertension.

NDRG1-HIF1α interaction in hypoxic signaling for pulmonary hypertension.

Journal: International journal of biological macromolecules

Published: May 21, 2025

Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension.

Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension.

Journal: Cellular signalling

Published: March 15, 2025

SP1/ADAM10/DRP1 axis links intercellular communication between smooth muscle cells and endothelial cells under hypoxia pulmonary hypertension.

SP1/ADAM10/DRP1 axis links intercellular communication between smooth muscle cells and endothelial cells under hypoxia pulmonary hypertension.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: October 25, 2024

Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p.

Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p.

Journal: International journal of nanomedicine

Published: August 25, 2024

Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension.

Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension.

Journal: International immunopharmacology

Published: January 09, 2024

MicroRNA153 induces apoptosis by targeting NFATc3 to improve vascular remodeling in pulmonary hypertension.

MicroRNA153 induces apoptosis by targeting NFATc3 to improve vascular remodeling in pulmonary hypertension.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)

Published: November 14, 2022

Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension.

Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: October 27, 2022

Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes.

Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes.

Journal: Chemical & pharmaceutical bulletin

Published: October 02, 2022

In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression.

In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression.

Journal: Pharmaceutical biology

Published: August 09, 2022

Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-κB signaling pathway and Nrf2/HO-1 axis.

Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-κB signaling pathway and Nrf2/HO-1 axis.

Journal: Stem cell research & therapy

Published: July 26, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026